Yi-Chung Hsieh

38PUBLICATIONS
76CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Software quality, processes and metricsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 02, 2026
Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

|Jun 19, 2026
Trifluridine/tipiracil and survival in mismatch repair-deficient metastatic colorectal cancer.

|Oct 22, 2025
Prognostic Significance of Circulating Tumor Cells in Patients with Esophageal Cancer Who Attained Pathological Complete Response after Neoadjuvant Therapy.

Chia-Hsun Hsieh, Chuan Cheng, Yu-Wen Wen

|Oct 21, 2025
Combination of the Circulating Tumor Cell Enumeration and the Fecal Immunochemical Test for Colorectal Neoplasia Prediction and Risk Evaluation of Colorectal Cancer.

Thi Ngoc Anh Nguyen, Sherry Yueh-Hsia Chiu, Jeng-Fu You

|Aug 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study.

Nai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai

|Apr 28, 2025
Integrating Pathologic Stage and Perioperative Circulating Tumor Cell Variations: Early Relapse Prediction Model for Resectable Non-Small Cell Lung Cancer.

Jui-Ying Fu, Chih-Tsung Wen, Ching-Feng Wu

Pageof 7

Frequent Collaborators

7 joint publications

Chih-Hua Yeh

7 joint publications

Chun-Ta Liao

6 joint publications

Chine-Yu Lin

6 joint publications

Chung-Jan Kang